127 related articles for article (PubMed ID: 4144552)
1. Drug-induced extrapyramidal symptoms. A cooperative study.
JAMA; 1973 May; 224(6):889-91. PubMed ID: 4144552
[No Abstract] [Full Text] [Related]
2. [Letter: Tardive dyskinesia, a little-known extrapyramidal syndrome due to therapy with neuroleptics].
Berchtold P; Hinssen M; Irmscher K
Dtsch Med Wochenschr; 1974 Mar; 99(9):420-1. PubMed ID: 4151333
[No Abstract] [Full Text] [Related]
3. Efficacy of thiopropazate dihydrochloride (Dartalan) in treating persisting phenothiazine-induced choreo-athetosis and akathisia.
Bullock RJ
Med J Aust; 1972 Aug; 2(6):314-6. PubMed ID: 4404280
[No Abstract] [Full Text] [Related]
4. [Extrapyramidal movement disorders arising during treatment of psychoses with drugs].
Vatsek Ia
Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(3):453-7. PubMed ID: 4940
[No Abstract] [Full Text] [Related]
5. Neuroleptics and neurologic reactions.
Marcotte DB
South Med J; 1973 Mar; 66(3):321-4. PubMed ID: 4144147
[No Abstract] [Full Text] [Related]
6. The rabbit syndrome. A peculiar extrapyramidal reaction.
Villeneuve A
Can Psychiatr Assoc J; 1972; 17(2):Suppl 2:SS69-. PubMed ID: 5042912
[No Abstract] [Full Text] [Related]
7. [Neuroleptics].
Rise A
Tidsskr Nor Laegeforen; 1976 Mar; 96(7):446-7. PubMed ID: 3864
[No Abstract] [Full Text] [Related]
8. [Secondary neurologic manifestations of psychotropic therapeutics. Neurophysiological approach].
Rigal J; Savelli A; Juillet P
Ann Med Interne (Paris); 1972 May; 123(5):541-7. PubMed ID: 4263578
[No Abstract] [Full Text] [Related]
9. Evolutionary origin of extrapyramidal disorders in drug-treated mental patients, its significance, and the role of neuromelanin.
Forrest FM
Adv Biochem Psychopharmacol; 1974; 9(0):255-68. PubMed ID: 4151764
[No Abstract] [Full Text] [Related]
10. Neuroleptic-induced tardiave dyskinesias in nonpsychotic patients.
Klawans HL; Bergen D; Bruyn GW; Paulson GW
Arch Neurol; 1974 Apr; 30(4):338-9. PubMed ID: 4816841
[No Abstract] [Full Text] [Related]
11. Neuroleptic-associated catatonic reaction.
Dorevitch A; Gabbay F
Clin Pharm; 1983; 2(6):581-2. PubMed ID: 6140097
[No Abstract] [Full Text] [Related]
12. Editorial: Tardive dyskinesias.
Hussey HH
JAMA; 1974 May; 228(8):1030. PubMed ID: 4406343
[No Abstract] [Full Text] [Related]
13. [Drug-induced extrapyramidal symptoms].
Janzik HH
Dtsch Med Wochenschr; 1975 Mar; 100(11):555-7. PubMed ID: 1116439
[No Abstract] [Full Text] [Related]
14. [Transitory exacerbations arising during the course of neuroleptic therapy].
Gurovich IIa
Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(6):919-25. PubMed ID: 5471621
[No Abstract] [Full Text] [Related]
15. [Morpho-functional changes in the pyramidal and extrapyramidal systems due to triftazin].
Krivitskaia GN; Sysoeva AF
Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(7):1063-8. PubMed ID: 4627828
[No Abstract] [Full Text] [Related]
16. [Study of extrapyramidal manifestations induced by neuroleptics].
Bordeleau JM; Tétreault L
Rev Can Biol; 1972; 31():Suppl:247-53. PubMed ID: 4403291
[No Abstract] [Full Text] [Related]
17. [Neuroleptics and extrapyramidal effects: correlation between antipsychotic and extrapyramidal properties].
Tetreault L; Filotto J; Bordeleau JM
Can Psychiatr Assoc J; 1968 Dec; 13(6):507-12. PubMed ID: 5726835
[No Abstract] [Full Text] [Related]
18. Practical therapeutics. Psychotropic drugs.
Steinhart MJ
Am Fam Physician; 1975 Aug; 12(2):92-101. PubMed ID: 238380
[No Abstract] [Full Text] [Related]
19. [Late irreversible extrapyramidal syndrome following neuroleptic use].
Boucebci M
Acta Psychiatr Belg; 1972 Mar; 72(2):233-40. PubMed ID: 5056017
[No Abstract] [Full Text] [Related]
20. Drug induced extrapyramidal effects--a review.
Coleman JH; Hayes PE
Dis Nerv Syst; 1975 Oct; 36(10):591-3. PubMed ID: 1100334
[No Abstract] [Full Text] [Related]
[Next] [New Search]
